Advertisement
JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Originally published In Press as doi:10.1074/jbc.M300319200 on February 21, 2003

J. Biol. Chem., Vol. 278, Issue 18, 15473-15483, May 2, 2003
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
278/18/15473    most recent
M300319200v1
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Carr, B. A.
Right arrow Articles by Yost, G. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Carr, B. A.
Right arrow Articles by Yost, G. S.
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Characterization of the Human Lung CYP2F1 Gene and Identification of a Novel Lung-specific Binding Motif*

Brian A. CarrDagger , Jie WanDagger , Ronald N. Hines§, and Garold S. YostDagger

From the Dagger  Department of Pharmacology and Toxicology, University of Utah, Salt Lake City, Utah 84112 and § Department of Pediatrics, Medical College of Wisconsin, Milwaukee, Wisconsin 53226-4801

The CYP2F1 gene encodes a cytochrome P450 enzyme capable of bioactivating a number of pulmonary-selective toxicants. The expression of CYP2F1 is highly tissue-selective; the highest expression is observed in the lung with little or no hepatic expression. The objective of these studies was to elucidate the mechanisms that govern the unique tissue-specific regulation of CYP2F1. Cosmid and bacterial artificial chromosome clones were screened and sequenced to identify a gene that spanned 14 kbp containing 10 exons, including an untranslated exon 1. Primer extension analysis and 5'-rapid amplification of cDNA ends were used to identify the transcription start site. Several sequences homologous to known cis-elements were identified in the 5'-upstream region of the CYP2F1 promoter. Transient transfection studies with luciferase reporter constructs demonstrated a significant functional lung cell-specific CYP2F1 promoter region (from position -129 to +115). DNase footprinting analysis of 1.6 kbp of the upstream sequence with nuclear extracts from human lung tissues revealed one strong DNA-protein complex at -152 to -182. This nuclear protein (called lung-specific factor, LSF) was present only in lung but not liver or heart tissues. Competitive electrophoretic mobility shift assays characterized a DNA consensus site, within the LSF-binding domain, that was highly similar to two E box motifs, but no known "E box" trans-factors were identified. These studies identified a novel LSF and its consensus sequence that may control tissue-specific expression of CYP2F1.

* This work was supported by NHLBI Grant HL60143 from the National Institutes of Health.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

The nucleotide sequence(s) reported in this paper has been submitted to the GenBankTM/EBI Data Bank with accession number(s) NM_000774.

To whom correspondence should be addressed: Dept. of Pharmacology and Toxicology, 30 S. 2000 E., Rm. 201, University of Utah, Salt Lake City, UT 84112. Tel.: 801-581-7956; Fax: 801-585-3945; E-mail: gyost@pharm.utah.edu.

Copyright © 2003 by The American Society for Biochemistry and Molecular Biology, Inc.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
 Mol. Pharmacol.Home page
J. S. Biggs, J. Wan, N. S. Cutler, J. Hakkola, P. Uusimaki, H. Raunio, and G. S. Yost
Transcription Factor Binding to a Putative Double E-Box Motif Represses CYP3A4 Expression in Human Lung Cells
Mol. Pharmacol., September 1, 2007; 72(3): 514 - 525.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Pharmacol.Home page
G. Ling, Y. Wei, and X. Ding
Transcriptional Regulation of Human CYP2A13 Expression in the Respiratory Tract by CCAAT/Enhancer Binding Protein and Epigenetic Modulation
Mol. Pharmacol., March 1, 2007; 71(3): 807 - 816.
[Abstract] [Full Text] [PDF]

Home page
 Drug Metab. Dispos.Home page
I. Girault, N. Rougier, C. Chesne, R. Lidereau, P. Beaune, I. Bieche, and I. de Waziers
SIMULTANEOUS MEASUREMENT OF 23 ISOFORMS FROM THE HUMAN CYTOCHROME P450 FAMILIES 1 TO 3 BY QUANTITATIVE REVERSE TRANSCRIPTASE-POLYMERASE CHAIN REACTION
Drug Metab. Dispos., December 1, 2005; 33(12): 1803 - 1810.
[Abstract] [Full Text] [PDF]

Home page
 Drug Metab. Dispos.Home page
X. Zhang, Q.-Y. Zhang, D. Liu, T. Su, Y. Weng, G. Ling, Y. Chen, J. Gu, B. Schilling, and X. Ding
EXPRESSION OF CYTOCHROME P450 AND OTHER BIOTRANSFORMATION GENES IN FETAL AND ADULT HUMAN NASAL MUCOSA
Drug Metab. Dispos., October 1, 2005; 33(10): 1423 - 1428.
[Abstract] [Full Text] [PDF]

Home page
 Drug Metab. Dispos.Home page
J. Wan, B. A. Carr, N. S. Cutler, D. L. Lanza, R. N. Hines, and G. S. Yost
SP1 AND SP3 REGULATE BASAL TRANSCRIPTION OF THE HUMAN CYP2F1 GENE
Drug Metab. Dispos., August 1, 2005; 33(8): 1244 - 1253.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
G. Ling, C. R. Hauer, R. M. Gronostajski, B. T. Pentecost, and X. Ding
Transcriptional Regulation of Rat CYP2A3 by Nuclear Factor 1: IDENTIFICATION OF A NOVEL NFI-A ISOFORM, AND EVIDENCE FOR TISSUE-SELECTIVE INTERACTION OF NFI WITH THE CYP2A3 PROMOTER IN VIVO
J. Biol. Chem., July 2, 2004; 279(27): 27888 - 27895.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2003 by the American Society for Biochemistry and Molecular Biology.
Advertisement
spacer
Advertisement
Advertisement